glp-1 and chronic fatigue syndrome Can Medications Help MCAS, Fatigue, More? The Potential Indirect Impact of

Looking Ahead One of the big unanswered questions with GLP-1 therapy is what happens when patients stop taking the medication

These immune cells are highly susceptible to oxidative damage, which can impair their function

Response from the owner: Thank you Julia

Secondly, the identification of hormetic substances in food is currently limited, often focusing on a few well-characterized compounds, leading to a likely underestimation of the full spectrum of beneficial food-derived hormetins

While this provides quick results, it also means your pituitary gland receives no signal to produce its own growth hormone, potentially leading to glandular suppression over time